Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus-2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperEditorialResearchpeer-review

DOI

  • Thomas R. O'Brien, National Institutes of Health
  • ,
  • David L. Thomas, Johns Hopkins University
  • ,
  • Sarah S. Jackson, National Institutes of Health
  • ,
  • Ludmila Prokunina-Olsson, National Institutes of Health
  • ,
  • Raymond P. Donnelly, United States Food and Drug Administration
  • ,
  • Rune Hartmann
Original languageEnglish
JournalClinical Infectious Diseases
Volume71
Issue6
Pages (from-to)1410-12
Number of pages3
ISSN1058-4838
DOIs
Publication statusPublished - 2020

    Research areas

  • innate immunity, MERS-CoV, Middle East respiratory syndrome, public health, SARS-CoV, severe acute respiratory syndrome, virology

See relations at Aarhus University Citationformats

ID: 188823899